BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 15591152)

  • 1. The vascular endothelial growth factor (VEGF)/VEGF receptor 2 pathway is critical for blood vessel survival in corpora lutea of pregnancy in the rodent.
    Pauli SA; Tang H; Wang J; Bohlen P; Posser R; Hartman T; Sauer MV; Kitajewski J; Zimmermann RC
    Endocrinology; 2005 Mar; 146(3):1301-11. PubMed ID: 15591152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea.
    Zimmermann RC; Hartman T; Bohlen P; Sauer MV; Kitajewski J
    Microvasc Res; 2001 Jul; 62(1):15-25. PubMed ID: 11421657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the vascular endothelial cell (VE)-specific adhesion molecule VE-cadherin blocks gonadotropin-dependent folliculogenesis and corpus luteum formation and angiogenesis.
    Nakhuda GS; Zimmermann RC; Bohlen P; Liao F; Sauer MV; Kitajewski J
    Endocrinology; 2005 Mar; 146(3):1053-9. PubMed ID: 15591148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
    Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy.
    Berisha B; Schams D; Kosmann M; Amselgruber W; Einspanier R
    Biol Reprod; 2000 Oct; 63(4):1106-14. PubMed ID: 10993833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40).
    Wulff C; Wilson H; Rudge JS; Wiegand SJ; Lunn SF; Fraser HM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3377-86. PubMed ID: 11443214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular dynamics in relation to immunolocalisation of VEGF-A, VEGFR-2 and Ang-2 in the bovine corpus luteum.
    Hünigen H; Bisplinghoff P; Plendl J; Bahramsoltani M
    Acta Histochem; 2008; 110(6):462-72. PubMed ID: 18541291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.
    Gomez R; Gonzalez-Izquierdo M; Zimmermann RC; Novella-Maestre E; Alonso-Muriel I; Sanchez-Criado J; Remohi J; Simon C; Pellicer A
    Endocrinology; 2006 Nov; 147(11):5400-11. PubMed ID: 16901966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of Flk-1/vascular endothelial growth factor receptor-2 in fibroblast growth factor receptor-1-deficient vascular stem cell development.
    Magnusson P; Rolny C; Jakobsson L; Wikner C; Wu Y; Hicklin DJ; Claesson-Welsh L
    J Cell Sci; 2004 Mar; 117(Pt 8):1513-23. PubMed ID: 15020678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and localization of vascular endothelial growth factor and its receptors in pig corpora lutea during the oestrous cycle.
    Boonyaprakob U; Gadsby JE; Hedgpeth V; Routh P; Almond GW
    Reproduction; 2003 Sep; 126(3):393-405. PubMed ID: 12968947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy.
    Sugino N; Kashida S; Takiguchi S; Karube A; Kato H
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3919-24. PubMed ID: 11061557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis in the corpus luteum of early pregnancy in the marmoset and the effects of vascular endothelial growth factor immunoneutralization on establishment of pregnancy.
    Rowe AJ; Morris KD; Bicknell R; Fraser HM
    Biol Reprod; 2002 Oct; 67(4):1180-8. PubMed ID: 12297534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum.
    Al-zi'abi MO; Watson ED; Fraser HM
    Reproduction; 2003 Feb; 125(2):259-70. PubMed ID: 12578540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian vascular endothelial growth factor and vascular endothelial growth factor receptor patterns in reproductive aging.
    Yeh J; Kim BS; Peresie J
    Fertil Steril; 2008 May; 89(5 Suppl):1546-56. PubMed ID: 17889862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF, VEGFR-1 and VEGFR-2 immunoreactivity in the porcine arteries of vascular subovarian plexus (VSP) during the estrous cycle.
    Postek A; Andronowska A; Doboszyńska T; Niewegłowski H; Jankowska K
    Folia Histochem Cytobiol; 2006; 44(1):17-23. PubMed ID: 16584087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular composition, apoptosis, and expression of angiogenic factors in the corpus luteum during prostaglandin F2alpha-induced regression in sheep.
    Vonnahme KA; Redmer DA; Borowczyk E; Bilski JJ; Luther JS; Johnson ML; Reynolds LP; Grazul-Bilska AT
    Reproduction; 2006 Jun; 131(6):1115-26. PubMed ID: 16735551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse.
    Douglas NC; Tang H; Gomez R; Pytowski B; Hicklin DJ; Sauer CM; Kitajewski J; Sauer MV; Zimmermann RC
    Endocrinology; 2009 Aug; 150(8):3845-54. PubMed ID: 19406950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of VEGF and its receptors in the corpus luteum of the bitch during diestrus and anestrus.
    Mariani TC; do Prado C; Silva LG; Paarmann FA; Lima MC; Carvalho I; Campos DB; Artoni LP; Hernandez-Blazquez FJ; Papa PC
    Theriogenology; 2006 Oct; 66(6-7):1715-20. PubMed ID: 16569426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.